Joseph Lee Roswarski MD FACP
Hematologic Oncology
Lymphoma, Hematologic Malignancies Division; Lombardi Comprehensive Cancer Center; Medstar Georgetown University Hospital; Regional Cancer Care Associates
Join to View Full Profile
3800 Reservoir Rd NWWashington, DC 20007
Phone+1 202-444-2223
Fax+1 866-871-7321
Dr. Roswarski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Joseph Roswarski is a hematologist oncologist in Washington, DC and is affiliated with MedStar Georgetown University Hospital and the Lombardi Comprehensive Cancer Center. He received his medical degree from Indiana University School of Medicine and has been in practice 11 years. He specializes in malignant hematology with focus on aggressive/indolent lymphomas, CLL, and multiple myeloma.
Education & Training
National Capital ConsortiumFellowship, Hematology and Medical Oncology, 2014 - 2017- National Capital ConsortiumResidency, Internal Medicine, 2012 - 2014
- National Capital ConsortiumInternship, Internal Medicine, 2011 - 2012
Indiana University School of MedicineClass of 2011
Certifications & Licensure
DC State Medical License 2022 - 2026
VA State Medical License 2013 - 2026
MD State Medical License 2022 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsHodgkin lymphoma: Focus on evolving treatment paradigms.Joseph L Roswarski, Dan L Longo
Best Practice & Research. Clinical Haematology. 2023-12-01 - 2 citationsSevere Lenalidomide-Associated Hyperbilirubinemia.Daniel T Gildea, Joseph L Roswarski
Cureus. 2023-01-01 - 15 citationsCarfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering ...Dickran Kazandjian, Elizabeth M. Hill, Alexander Dew, Candis Morrison, Joseph Roswarski
JAMA Oncology. 2021-11-01
Journal Articles
- Hodgkin lymphoma: Focus on evolving treatment paradigmsJoseph L. Roswarski, Dan L. Longo, Best Practice & Research Clinical Haematology, 10/27/2023
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
